William Pickering
Stock Analyst at Bernstein
(1.75)
# 3,052
Out of 4,784 analysts
23
Total ratings
46.67%
Success rate
-1.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $271.02 | +14.38% | 2 | Jan 7, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $1,110 → $1,070 | $635.83 | +68.28% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $13.80 | +73.91% | 2 | Nov 29, 2024 | |
| BHVN Biohaven | Maintains: Outperform | $55 → $66 | $28.39 | +132.48% | 2 | Sep 24, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $116 → $90 | $72.83 | +23.58% | 4 | Sep 17, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $31.72 | - | 2 | Jun 14, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Market Perform | n/a | $502.55 | - | 5 | Feb 2, 2024 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | $54 | $8.40 | +542.86% | 1 | Mar 21, 2023 | |
| BEAM Beam Therapeutics | Initiates: Market Perform | $37 | $22.19 | +66.74% | 1 | Mar 21, 2023 | |
| ALLO Allogene Therapeutics | Initiates: Market Perform | $6 | $1.56 | +284.62% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $38.04 | +15.67% | 1 | Mar 21, 2023 |
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $271.02
Upside: +14.38%
Regeneron Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $1,110 → $1,070
Current: $635.83
Upside: +68.28%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $13.80
Upside: +73.91%
Biohaven
Sep 24, 2024
Maintains: Outperform
Price Target: $55 → $66
Current: $28.39
Upside: +132.48%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Outperform
Price Target: $116 → $90
Current: $72.83
Upside: +23.58%
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $31.72
Upside: -
Vertex Pharmaceuticals
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $502.55
Upside: -
Intellia Therapeutics
Mar 21, 2023
Initiates: Outperform
Price Target: $54
Current: $8.40
Upside: +542.86%
Beam Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $22.19
Upside: +66.74%
Allogene Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.56
Upside: +284.62%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $38.04
Upside: +15.67%